An open letter to all members of the IASLC [1]

Lung Cancer

Volumn 45, Issue 1, 2004, Pages 119-120

  Macbeth, Fergus ^a   Stephens, Richard ^b   Abratt, Raymond P ^c   Arriagada, Roderigo ^d   Ball, David ^e   Bezjak, Andrea ^f   Billingham, Lucinda ^g   Crowley, John ^h   O'Brien, Mary ⁱ   Shakespeare, Tom ^j   Thompson, Elinor ^k   Van Meerbeeck, Jan ^l  

^a VELINDRE CANCER CENTRE   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Instituto de Radiomedicina Santiago   (Chile)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ ROYAL MARSDEN HOSPITAL   (United Kingdom)

^j NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^k HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^l GHENT UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; CANCER THERAPY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HEALTH PRACTITIONER; HUMAN; JAPAN; LETTER; LUNG CANCER; MEDICAL LITERATURE; PRIORITY JOURNAL;

EID: 2942522586     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.04.001     Document Type: Editorial

References (4)

1. Stephens R. Time for a global strategy to improve the treatment of lung cancer? Lung Cancer. 31(2-3):2001;349
2. Macbeth F. A global strategy must be a priority for the IASLC. Lung Cancer. 34:2001;461
3. Stephens R. The need for a world strategy for clinical trials. Lung Cancer. 1(S3):2003;S96
4. Crowley J. Lung cancer clinical trials: principles and pitfalls. Lung Cancer. 41(S3):2003;S26